File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma

TitlePlacental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma
Authors
KeywordsCholangiocarcinoma
Hepatic fibrosis
Issue Date2021
PublisherBMJ Publishing Group. The Journal's web site is located at http://gut.bmjjournals.com/
Citation
Gut, 2021, v. 71 n. 1, p. 185-193 How to Cite?
AbstractObjective: Intrahepatic cholangiocarcinoma (ICC)-a rare liver malignancy with limited therapeutic options-is characterised by aggressive progression, desmoplasia and vascular abnormalities. The aim of this study was to determine the role of placental growth factor (PlGF) in ICC progression. Design: We evaluated the expression of PlGF in specimens from ICC patients and assessed the therapeutic effect of genetic or pharmacologic inhibition of PlGF in orthotopically grafted ICC mouse models. We evaluated the impact of PlGF stimulation or blockade in ICC cells and cancer-associated fibroblasts (CAFs) using in vitro 3-D coculture systems. Results: PlGF levels were elevated in human ICC stromal cells and circulating blood plasma and were associated with disease progression. Single-cell RNA sequencing showed that the major impact of PlGF blockade in mice was enrichment of quiescent CAFs, characterised by high gene transcription levels related to the Akt pathway, glycolysis and hypoxia signalling. PlGF blockade suppressed Akt phosphorylation and myofibroblast activation in ICC-derived CAFs. PlGF blockade also reduced desmoplasia and tissue stiffness, which resulted in reopening of collapsed tumour vessels and improved blood perfusion, while reducing ICC cell invasion. Moreover, PlGF blockade enhanced the efficacy of standard chemotherapy in mice-bearing ICC. Conclusion PlGF blockade leads to a reduction in intratumorous hypoxia and metastatic dissemination, enhanced chemotherapy sensitivity and increased survival in mice-bearing aggressive ICC.
Persistent Identifierhttp://hdl.handle.net/10722/305837
ISSN
2023 Impact Factor: 23.0
2023 SCImago Journal Rankings: 8.052
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorAoki, S-
dc.contributor.authorInoue, K-
dc.contributor.authorKlein, S-
dc.contributor.authorHalvorsen, S-
dc.contributor.authorChen, J-
dc.contributor.authorMatsui, A-
dc.contributor.authorNikmaneshi, MR-
dc.contributor.authorKitahara, S-
dc.contributor.authorHato, T-
dc.contributor.authorChen, X-
dc.contributor.authorKawakubo, K-
dc.contributor.authorNia, HT-
dc.contributor.authorChen, I-
dc.contributor.authorSchanne, DH-
dc.contributor.authorMamessier, E-
dc.contributor.authorShigeta, K-
dc.contributor.authorKikuchi, H-
dc.contributor.authorRamjiawan, RR-
dc.contributor.authorSchmidt, TC-
dc.contributor.authorIwasaki, M-
dc.contributor.authorYau, TCC-
dc.contributor.authorHong, TS-
dc.contributor.authorQuaas, A-
dc.contributor.authorPlum, PS-
dc.contributor.authorDima, S-
dc.contributor.authorPopescu, I-
dc.contributor.authorBardeesy, N-
dc.contributor.authorMunn, LL-
dc.contributor.authorBorad, MJ-
dc.contributor.authorSassi, S-
dc.contributor.authorJain, RK-
dc.contributor.authorZhu, AX-
dc.contributor.authorDuda, DG-
dc.date.accessioned2021-10-20T10:15:01Z-
dc.date.available2021-10-20T10:15:01Z-
dc.date.issued2021-
dc.identifier.citationGut, 2021, v. 71 n. 1, p. 185-193-
dc.identifier.issn0017-5749-
dc.identifier.urihttp://hdl.handle.net/10722/305837-
dc.description.abstractObjective: Intrahepatic cholangiocarcinoma (ICC)-a rare liver malignancy with limited therapeutic options-is characterised by aggressive progression, desmoplasia and vascular abnormalities. The aim of this study was to determine the role of placental growth factor (PlGF) in ICC progression. Design: We evaluated the expression of PlGF in specimens from ICC patients and assessed the therapeutic effect of genetic or pharmacologic inhibition of PlGF in orthotopically grafted ICC mouse models. We evaluated the impact of PlGF stimulation or blockade in ICC cells and cancer-associated fibroblasts (CAFs) using in vitro 3-D coculture systems. Results: PlGF levels were elevated in human ICC stromal cells and circulating blood plasma and were associated with disease progression. Single-cell RNA sequencing showed that the major impact of PlGF blockade in mice was enrichment of quiescent CAFs, characterised by high gene transcription levels related to the Akt pathway, glycolysis and hypoxia signalling. PlGF blockade suppressed Akt phosphorylation and myofibroblast activation in ICC-derived CAFs. PlGF blockade also reduced desmoplasia and tissue stiffness, which resulted in reopening of collapsed tumour vessels and improved blood perfusion, while reducing ICC cell invasion. Moreover, PlGF blockade enhanced the efficacy of standard chemotherapy in mice-bearing ICC. Conclusion PlGF blockade leads to a reduction in intratumorous hypoxia and metastatic dissemination, enhanced chemotherapy sensitivity and increased survival in mice-bearing aggressive ICC.-
dc.languageeng-
dc.publisherBMJ Publishing Group. The Journal's web site is located at http://gut.bmjjournals.com/-
dc.relation.ispartofGut-
dc.rightsGut. Copyright © BMJ Publishing Group.-
dc.subjectCholangiocarcinoma-
dc.subjectHepatic fibrosis-
dc.titlePlacental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma-
dc.typeArticle-
dc.identifier.emailYau, TCC: tyaucc@hku.hk-
dc.identifier.authorityYau, TCC=rp01466-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1136/gutjnl-2020-322493-
dc.identifier.pmid33431577-
dc.identifier.pmcidPMC8666816-
dc.identifier.scopuseid_2-s2.0-85099387425-
dc.identifier.hkuros326656-
dc.identifier.volume71-
dc.identifier.issue1-
dc.identifier.spage185-
dc.identifier.epage193-
dc.identifier.isiWOS:000728888500001-
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats